Movement Alert|Twist Bioscience Corp Intraday Rise 5.27%, Jefferies Hold Rating Eases Valuation Divergence

Market Focus
Yesterday

On October 9, Twist Bioscience Corp rose 5.27% in regular trading, trading at $160.06 per share, with turnover of $37.65 million. The move follows Jefferies initiating coverage with a Hold rating and a $150 price target, which, while offering limited upside, eased near-term valuation divergence and released some selling pressure.

Background shows the stock had fallen 5.63% the prior session amid broad biotech weakness and heightened valuation concerns in the synthetic DNA space. Jefferies' price target provided an anchor for recent volatility, helping stabilize sentiment despite the target being near current trading levels.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10